GB1419788A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
Herbicidal method using 2-trifuluromethyl-4-quinolinols
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
DE69315920T2
(de)
|
1992-09-04 |
1998-06-10 |
Takeda Chemical Industries Ltd |
Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
|
EP0683234B2
(en)
|
1993-01-25 |
2007-06-06 |
Takeda Chemical Industries, Ltd. |
Antibody against beta-amyloid or their derivative and use thereof
|
DE69628484T2
(de)
|
1995-03-24 |
2004-05-19 |
Takeda Chemical Industries, Ltd. |
Zyklische Verbindungen, ihre Herstellung und ihre Verwendung als Tachykininrezeptorantagonisten
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
DK0994728T3
(da)
|
1997-04-09 |
2008-12-01 |
Intellect Neurosciences Inc |
Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf
|
US6929808B2
(en)
|
2000-11-03 |
2005-08-16 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
JP3537394B2
(ja)
|
1998-03-03 |
2004-06-14 |
ピーピージー インダストリーズ オハイオ, インコーポレイテッド |
含浸ガラス繊維ストランドおよびそれを含む製品
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
CA2352612A1
(en)
|
1998-11-27 |
2000-06-08 |
Hideo Fukui |
Pharmaceuticals
|
EP1257584B2
(en)
|
2000-02-24 |
2013-03-06 |
Washington University St. Louis |
Humanized antibodies that sequester amyloid beta peptide
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
JP2005503789A
(ja)
|
2001-08-17 |
2005-02-10 |
イーライ・リリー・アンド・カンパニー |
抗Aβ抗体
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
WO2004032868A2
(en)
|
2002-10-09 |
2004-04-22 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
BR0315158A
(pt)
|
2002-10-09 |
2005-08-16 |
Pfizer Prod Inc |
Compostos de pirazol para o tratamento de distúrbios neurodegenarativos
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
MXPA05013770A
(es)
|
2003-06-19 |
2006-03-08 |
Pfizer Prod Inc |
Antagonista de neuroquinina 1.
|
MXPA06001845A
(es)
|
2003-08-21 |
2006-05-04 |
Pfizer Prod Inc |
Compuestos para el tratamiento de trastornos neurodegenerativos.
|
EP1666061A1
(en)
|
2003-09-09 |
2006-06-07 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
AU2005208887B2
(en)
|
2004-01-28 |
2010-02-25 |
Merck Sharp & Dohme Corp. |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
WO2005080361A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
JP2007528394A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害薬
|
PL1730119T3
(pl)
|
2004-03-23 |
2008-10-31 |
Pfizer Products Incorporated |
Związki imidazolowe do leczenia zaburzeń neurodegeneracyjnych
|
PT1742642E
(pt)
|
2004-04-14 |
2009-01-23 |
Gilead Sciences Inc |
Análogos de fosfonato de compostos inibidores da integrase do hiv
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
WO2006036291A2
(en)
|
2004-07-30 |
2006-04-06 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
US20090074775A1
(en)
|
2004-12-22 |
2009-03-19 |
David Michael Holtzman |
Use Of Anti-AB Antibody To Treat Traumatic Brain Injury
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
CA2607151C
(en)
|
2005-05-10 |
2012-06-19 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
EP1881985B1
(en)
|
2005-05-12 |
2010-12-29 |
Pfizer, Inc. |
Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
EP1899296B1
(en)
|
2005-06-22 |
2010-11-17 |
Pfizer Products Inc. |
Histamine-3 receptor antagonists
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
WO2007062332A2
(en)
|
2005-11-18 |
2007-05-31 |
Glaxo Group Limited |
Novel intermediates and their use
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
JP5221144B2
(ja)
|
2005-11-24 |
2013-06-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
モルホリンタイプ・シンナミド化合物
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
EP1976843B1
(en)
|
2006-01-20 |
2013-09-04 |
Merck Sharp & Dohme Corp. |
Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
EP2007749A2
(en)
|
2006-03-13 |
2008-12-31 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
EP2013208B1
(en)
|
2006-04-21 |
2011-06-22 |
Pfizer Products Inc. |
Pyridin[3,4-b]pyrazinones
|
JP5271895B2
(ja)
|
2006-05-15 |
2013-08-21 |
メルク・シャープ・アンド・ドーム・コーポレーション |
抗糖尿病性の二環式化合物
|
EP2066670A2
(en)
|
2006-05-16 |
2009-06-10 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
CN101448793A
(zh)
|
2006-05-19 |
2009-06-03 |
卫材R&D管理有限公司 |
脲型肉桂酰胺衍生物
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
ES2395744T3
(es)
|
2007-01-22 |
2013-02-14 |
Pfizer Products Inc. |
Sal de tosilato de un compuesto terapéutico y sus composiciones farmacéuticas
|
US8252803B2
(en)
|
2007-02-12 |
2012-08-28 |
Merck Sharp & Dohme Corp. |
Piperidine derivatives
|
US20100204230A1
(en)
|
2007-02-12 |
2010-08-12 |
Peter Blurton |
Piperazine derivatives for treatment of ad and related conditions
|
US20080207900A1
(en)
|
2007-02-28 |
2008-08-28 |
Teiji Kimura |
Two cyclic oxomorphorin derivatives
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
KR20100017573A
(ko)
|
2007-05-07 |
2010-02-16 |
쉐링 코포레이션 |
감마 세크레타제 조정인자
|
AU2008250436B2
(en)
|
2007-05-11 |
2013-03-28 |
F. Hoffmann-La Roche Ag |
Hetarylanilines as modulators for amyloid beta
|
CL2008001540A1
(es)
|
2007-05-29 |
2009-05-22 |
Sgx Pharmaceuticals Inc |
Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
|
BRPI0812491A2
(pt)
|
2007-06-01 |
2014-12-02 |
Schering Corp |
Moduladores de gama secretase
|
BRPI0812170A8
(pt)
|
2007-06-01 |
2016-02-10 |
Schering Corp |
Moduladores de gama secretase
|
EP2166854A4
(en)
|
2007-06-13 |
2012-05-16 |
Merck Sharp & Dohme |
TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND ASSOCIATED STATES
|
CL2008001914A1
(es)
|
2007-06-29 |
2009-07-17 |
Schering Corp |
Compuestos heterociclicos de nitrogeno y oxigeno,moduladores de gama secretasa, composicion farmaceutica de dichos compuestos; kit farmaceutico y su uso para prevenir o tratar enfermedades asociadas al sistema nervioso central como alzheimer, sindrome de down, enfermedades neurodegenerativas, inhibir el deposito de proteina amiloide.
|
CA2695543A1
(en)
|
2007-08-06 |
2009-02-12 |
Schering Corporation |
Gamma secretase modulators
|
KR20100055456A
(ko)
|
2007-08-31 |
2010-05-26 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
다환식 화합물
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
CA2698341A1
(en)
|
2007-09-06 |
2009-03-12 |
Schering Corporation |
Gamma secretase modulators
|
US20100298381A1
(en)
|
2007-09-28 |
2010-11-25 |
Schering Corporation |
Gamma secretase modulators
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
MX2010005028A
(es)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Moduladores de gamma secretasa.
|
WO2009073779A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Schering Corporation |
Gamma secretase modulators
|
WO2009076352A1
(en)
|
2007-12-11 |
2009-06-18 |
Schering Corporation |
Gamma secretase modulators
|
US20100298372A1
(en)
|
2007-12-11 |
2010-11-25 |
Schering Corporation |
Gamma secretase modulators
|
US20110166132A1
(en)
|
2007-12-13 |
2011-07-07 |
Amgen Inc. |
Gamma Secretase Modulators
|
AU2009203773B2
(en)
|
2008-01-11 |
2013-04-18 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
RU2010137300A
(ru)
|
2008-02-22 |
2012-03-27 |
Ф. Хоффманн-Ля Рош Аг (Ch) |
Модуляторы бета-амилоида
|
CA2716747A1
(en)
|
2008-02-29 |
2009-09-03 |
Schering Corporation |
Gamma secretase modulators for the treatment of alzheimer's disease
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
MX2010011920A
(es)
|
2008-05-05 |
2010-11-26 |
Amgen Inc |
Compuestos de urea como moduladores de gamma secretasa.
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
US8685972B2
(en)
|
2008-08-13 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives for treatment of alzheimer's disease
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
EP2324009A1
(en)
|
2008-08-27 |
2011-05-25 |
Eisai R&D Management Co., Ltd. |
Process for preparing certain cinnamide compounds
|
JP5502089B2
(ja)
|
2008-10-09 |
2014-05-28 |
エフ.ホフマン−ラ ロシュ アーゲー |
アミロイドβのモジュレーター
|
JP2012508180A
(ja)
|
2008-11-06 |
2012-04-05 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
AU2009313538A1
(en)
|
2008-11-06 |
2010-05-14 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
BRPI0921317A2
(pt)
|
2008-11-06 |
2017-06-06 |
Astrazeneca Ab |
composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
|
BRPI0921348A2
(pt)
|
2008-11-10 |
2019-09-24 |
Hoffmann La Roche |
moduladores heterocíclicos da gama secretase
|
US20110313001A1
(en)
|
2008-12-16 |
2011-12-22 |
Christian Fischer |
Triazole derivatives for treatment of alzheimer's disease
|
US8575150B2
(en)
|
2008-12-16 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of Alzheimer's disease
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
EA020548B1
(ru)
|
2008-12-19 |
2014-12-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
|
AU2009330233A1
(en)
|
2008-12-22 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
EP2379566A2
(en)
|
2008-12-22 |
2011-10-26 |
Schering Corporation |
Gamma secretase modulators
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
UA106360C2
(ru)
|
2009-02-06 |
2014-08-26 |
Янссен Фармасьютікелз, Інк |
Замещенные бициклические гетероциклические соединения как модуляторы гамма-секретазы
|
TWI461425B
(zh)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
BRPI1007883A2
(pt)
|
2009-02-26 |
2016-02-23 |
Eisai R&D Man Co Ltd |
sal, e, cristal.
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
US20120053165A1
(en)
|
2009-03-03 |
2012-03-01 |
Pfizer Inc. |
Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
|
NZ597597A
(en)
|
2009-08-07 |
2014-01-31 |
Dow Agrosciences Llc |
Pesticidal compositions containing heteroaryl-n-aryl carbamate compounds
|
JP2013508350A
(ja)
*
|
2009-10-20 |
2013-03-07 |
ファイザー・インク |
ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール
|
CA2785499C
(en)
*
|
2009-12-22 |
2017-05-02 |
Vertex Pharmaceuticals Incorporated |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
EP2691393B1
(en)
|
2011-03-31 |
2016-09-14 |
Pfizer Inc |
Novel bicyclic pyridinones
|
ES2585009T3
(es)
*
|
2012-05-16 |
2016-10-03 |
Janssen Pharmaceuticals, Inc. |
Derivados de 3,4-dihidro-2H-pirido[1,2-a]pirazina-1,6-diona sustituidos útiles para el tratamiento de (inter alia) enfermedad de Alzheimer
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙(氟烷基)-1,4-苯并二氮呯酮化合物及其前藥
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
CN104918938B
(zh)
|
2012-12-20 |
2017-08-15 |
詹森药业有限公司 |
新颖的作为γ分泌酶调节剂的三环3,4‑二氢‑2H‑吡啶并[1,2‑a]吡嗪‑1,6‑二酮衍生物
|
CN104936958B
(zh)
|
2013-01-17 |
2019-07-26 |
詹森药业有限公司 |
作为γ分泌酶调节剂的新颖的经取代的吡啶并-哌嗪酮衍生物
|
EP3052495B1
(en)
|
2013-10-04 |
2019-06-26 |
Pfizer Inc |
Novel bicyclic pyridinones as gamma-secretase modulators
|
CN115068134A
(zh)
|
2014-03-21 |
2022-09-20 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
BR112016022519A8
(pt)
|
2014-04-01 |
2018-03-06 |
Pfizer |
cromeno e 1,1a,2,7b-tetra-hidrociclopropa[c]cromeno piridopirazinadionas como moduladores de gama-secretase
|